1. ？Strieter RM,Mehrad B. New mechanisms of pulmonary fibrosis. Chest,2009,136:1364-1370.
[2]
2. Barkauskas CE,Noble PW. Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis. Am J Physiol Cell Physiol,2014,306:C987-C996.
[3]
3. Fernandez IE,Eickelberg O. New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet,2012,380:680-688.
5. Renzoni E,Srihari V,Sestini P. Pathogenesis of idiopathic pulmonary fibrosis:review of recent findings. F1000Prime Rep,2014,6:69.
[6]
6. Spagnolo P,Rossi G,Cavazza A. Pathogenesis of idiopathic pulmonary fibrosis and its clinical implications. Expert Rev Clin Immunol,2014,10:1005-1017.
[7]
7. Williamson JD,Sadofsky LR,Hart SP. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis. Exp Lung Res,2015,41:57-73.
[8]
8. Simon R,Lam A,Li MC,et al. Analysis of gene expression data using BRB-ArrayTools. Cancer Inform,2007,3:11-17.
[9]
12. Peng R,Sridhar S,Tyagi G,et al. Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis:a model for "active" disease. PLoS One,2013,8:e59348.
9. Kaminski N,Rosas IO. Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis:can we identify the right target genes? Proc Am Thorac Soc,2006,3:339-344.
16. Lilja-Maula L,Syrja P,Laurila HP,et al. Comparative study of transforming growth factor-beta signalling and regulatory molecules in human and canine idiopathic pulmonary fibrosis. J Comp Pathol,2014,150:399-407.
